{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:06:32Z","timestamp":1788912392341,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Standardized Diagnosis and Treatment of Heart Failure","award":["2025cyjstg006"],"award-info":[{"award-number":["2025cyjstg006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58344-x","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:46:17Z","timestamp":1781873177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biomimetic macrophage membrane-coated nanoparticles for targeted cardioprotection against myocardial ischaemia-reperfusion injury"],"prefix":"10.1038","volume":"16","author":[{"given":"Hengheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiwen","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"58344_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","volume":"33","author":"M Algoet","year":"2023","unstructured":"Algoet, M. et al. Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc. Med. 33, 357\u2013366 (2023).","journal-title":"Trends Cardiovasc. Med."},{"key":"58344_CR2","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.jacc.2024.02.056","volume":"83","author":"FG Welt","year":"2024","unstructured":"Welt, F. G. et al. Reperfusion injury in patients with acute myocardial infarction: JACC scientific statement. J. Am. Coll. Cardiol. 83, 2196\u20132213 (2024).","journal-title":"J. Am. Coll. Cardiol."},{"key":"58344_CR3","doi-asserted-by":"publisher","first-page":"155649","DOI":"10.1016\/j.phymed.2024.155649","volume":"129","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury. Phytomedicine 129, 155649 (2024).","journal-title":"Phytomedicine"},{"key":"58344_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.medj.2023.12.007","volume":"5","author":"G Heusch","year":"2024","unstructured":"Heusch, G. Myocardial ischemia\/reperfusion: translational pathophysiology of ischemic heart disease. Med 5, 10\u201331 (2024).","journal-title":"Med"},{"key":"58344_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch, G. Myocardial ischaemia\u2013reperfusion injury and cardioprotection in perspective. Nat. Rev. Cardiol. 17, 773\u2013789 (2020).","journal-title":"Nat. Reviews Cardiol."},{"key":"58344_CR6","doi-asserted-by":"publisher","first-page":"9929687","DOI":"10.1155\/2021\/9929687","volume":"201","author":"W Zhao","year":"2021","unstructured":"Zhao, W. et al. Ferroptosis: opportunities and challenges in myocardial ischemia-reperfusion injury. Oxidative Med. Cell. Longev. 2021:9929687 (2021).","journal-title":"Oxidative Med. Cell. Longev."},{"key":"58344_CR7","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3390\/cells14191509","volume":"14","author":"MS Fede","year":"2025","unstructured":"Fede, M. S. et al. Myocardial ischemia\/reperfusion injury: molecular insights, forensic perspectives, and therapeutic horizons. Cells 14, 1509 (2025).","journal-title":"Cells"},{"key":"58344_CR8","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/biomedicines12040802","volume":"12","author":"M Sagris","year":"2024","unstructured":"Sagris, M. et al. Myocardial Ischemia\u2013Reperfusion injury: Unraveling pathophysiology, clinical manifestations, and emerging prevention strategies. Biomedicines 12, 802 (2024).","journal-title":"Biomedicines"},{"key":"58344_CR9","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.3390\/biomedicines13092084","volume":"13","author":"L Alsadder","year":"2025","unstructured":"Alsadder, L. et al. Cardiac iischaemia\u2013reperfusion injury: Pathophysiology, therapeutic targets and future interventions. Biomedicines 13, 2084 (2025).","journal-title":"Biomedicines"},{"key":"58344_CR10","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.2353\/ajpath.2010.090451","volume":"176","author":"J Chen","year":"2010","unstructured":"Chen, J. et al. Effects of CXCR4 gene transfer on cardiac function after ischemia-reperfusion injury. Am. J. Pathol. 176, 1705\u20131715 (2010).","journal-title":"Am. J. Pathol."},{"key":"58344_CR11","doi-asserted-by":"publisher","first-page":"11730","DOI":"10.3390\/ijms231911730","volume":"23","author":"KC Yeh","year":"2022","unstructured":"Yeh, K. C. et al. Protective effect of CXCR4 antagonist DBPR807 against ischemia-reperfusion injury in a rat and porcine model of myocardial infarction: potential adjunctive therapy for percutaneous coronary intervention. Int. J. Mol. Sci. 23, 11730 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"58344_CR12","doi-asserted-by":"publisher","first-page":"108999","DOI":"10.1016\/j.biopha.2019.108999","volume":"116","author":"A Rauf","year":"2019","unstructured":"Rauf, A. et al. Proanthocyanidins: A comprehensive review. Biomed. Pharmacother. 116, 108999 (2019).","journal-title":"Biomed. Pharmacother."},{"key":"58344_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12872-018-0772-x","volume":"18","author":"D Liu","year":"2018","unstructured":"Liu, D. Effects of procyanidin on cardiomyocyte apoptosis after myocardial ischemia reperfusion in rats. BMC Cardiovasc. Disord. 18, 35 (2018).","journal-title":"BMC Cardiovasc. Disord."},{"key":"58344_CR14","doi-asserted-by":"publisher","first-page":"102360","DOI":"10.1016\/j.nano.2021.102360","volume":"33","author":"A Zinger","year":"2021","unstructured":"Zinger, A. et al. Biomimetic nano drug delivery carriers for treating cardiovascular diseases. Nanomed. Nanotechnol. Biol. Med. 33, 102360 (2021).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"58344_CR15","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/molecules30040962","volume":"30","author":"Q Chen","year":"2025","unstructured":"Chen, Q. et al. Advanced nanomedicine delivery systems for cardiovascular diseases: Viral and non-viral strategies in targeted therapy. Molecules 30, 962 (2025).","journal-title":"Molecules"},{"key":"58344_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/biology12010082","volume":"12","author":"D Li","year":"2023","unstructured":"Li, D. et al. Nanoparticle based cardiac specific drug delivery. Biology 12, 82 (2023).","journal-title":"Biology"},{"key":"58344_CR17","doi-asserted-by":"publisher","first-page":"47145","DOI":"10.1021\/acsomega.4c07573","volume":"9","author":"T Li","year":"2024","unstructured":"Li, T. et al. Targeted treatment of myocardial infarction by macrophage membrane coated with resveratrol nanoparticles. ACS omega. 9, 47145\u201347155 (2024).","journal-title":"ACS omega"},{"key":"58344_CR18","doi-asserted-by":"publisher","first-page":"114414","DOI":"10.1016\/j.colsurfb.2024.114414","volume":"247","author":"X Bi","year":"2025","unstructured":"Bi, X. et al. Recent advances in biomimetic nanodelivery systems for the treatment of myocardial ischemia reperfusion injury. Colloids Surf., B. 247, 114414 (2025).","journal-title":"Colloids Surf., B"},{"key":"58344_CR19","doi-asserted-by":"publisher","first-page":"114159","DOI":"10.1016\/j.colsurfb.2024.114159","volume":"243","author":"F Lei","year":"2024","unstructured":"Lei, F. et al. Biomimetic nanoplatform treats myocardial ischemia\/reperfusion injury by synergistically promoting angiogenesis and inhibiting inflammation. Colloids Surf., B. 243, 114159 (2024).","journal-title":"Colloids Surf., B"},{"key":"58344_CR20","doi-asserted-by":"publisher","first-page":"33756","DOI":"10.1021\/acsami.1c03421","volume":"13","author":"Y Wei","year":"2021","unstructured":"Wei, Y. et al. Engineered biomimetic nanoplatform protects the myocardium against ischemia\/reperfusion injury by inhibiting pyroptosis. ACS Appl. Mater. Interfaces. 13, 33756\u201333766 (2021).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"58344_CR21","doi-asserted-by":"publisher","first-page":"13499","DOI":"10.2147\/IJN.S546817","volume":"20","author":"L Wang","year":"2025","unstructured":"Wang, L. et al. Macrophage membrane-coated nanocarriers in myocardial infarction: A paradigm shift in targeted cardiac therapy. Int. J. Nanomed. 20, 13499\u201313525 (2025).","journal-title":"Int. J. Nanomed."},{"key":"58344_CR22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.yjmcc.2011.02.003","volume":"50","author":"S Kanki","year":"2011","unstructured":"Kanki, S. et al. Identification of targeting peptides for ischemic myocardium by in vivo phage display. J. Mol. Cell. Cardiol. 50, 841\u2013848 (2011).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"58344_CR23","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1038\/s41467-020-16439-7","volume":"11","author":"C Gao","year":"2020","unstructured":"Gao, C. et al. Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat. Commun. 11, 2622 (2020).","journal-title":"Nat. Commun."},{"key":"58344_CR24","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/cvr\/cvz145","volume":"116","author":"P Boisguerin","year":"2020","unstructured":"Boisguerin, P. et al. A novel therapeutic peptide targeting myocardial reperfusion injury. Cardiovascular. Res. 116, 633\u2013644 (2020).","journal-title":"Cardiovascular. Res."},{"key":"58344_CR25","doi-asserted-by":"publisher","first-page":"7305","DOI":"10.3390\/molecules26237305","volume":"26","author":"NF Sangweni","year":"2021","unstructured":"Sangweni, N. F. et al. The implication of low dose dimethyl sulfoxide on mitochondrial function and oxidative damage in cultured cardiac and cancer cells. Molecules 26, 7305 (2021).","journal-title":"Molecules"},{"key":"58344_CR26","doi-asserted-by":"publisher","first-page":"103724","DOI":"10.1016\/j.xpro.2025.103724","volume":"6","author":"C Zhong","year":"2025","unstructured":"Zhong, C. et al. Protocol for the establishment of a mouse myocardial infarction and ischemia-reperfusion model via heart compression. STAR. Protocols. 6, 103724 (2025).","journal-title":"STAR. protocols"},{"key":"58344_CR27","doi-asserted-by":"publisher","DOI":"10.3791\/64387","author":"E Johny","year":"2022","unstructured":"Johny, E. et al. Left coronary artery ligation: A surgical murine model of myocardial infarction. J. Visualized Exp. JoVE. (2022). https:\/\/doi.org\/10.3791\/64387 (2022).","journal-title":"J. visualized experiments: JoVE"},{"key":"58344_CR28","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.2967\/jnumed.114.141861","volume":"55","author":"C P\u00e9rez-Medina","year":"2014","unstructured":"P\u00e9rez-Medina, C. et al. A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting. J. Nucl. Med. 55, 1706\u20131711 (2014).","journal-title":"J. Nucl. Med."},{"key":"58344_CR29","first-page":"5918","volume":"12","author":"R Dasiman","year":"2022","unstructured":"Dasiman, R. et al. A review of procyanidin: Updates on current bioactivities and potential health benefits. Biointerface Res. Appl. Chem. 12, 5918\u20135940 (2022).","journal-title":"Biointerface Res. Appl. Chem."},{"key":"58344_CR30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/jat.3749","volume":"39","author":"Mu\u00f1oz-S\u00e1nchez","year":"2019","unstructured":"Mu\u00f1oz-S\u00e1nchez et al. The use of cobalt chloride as a chemical hypoxia model. J. Appl. Toxicol. 39, 556\u2013570 (2019).","journal-title":"J. Appl. Toxicol."},{"key":"58344_CR31","first-page":"4777","volume":"15","author":"G Calvo\u2013Anguiano","year":"2018","unstructured":"Calvo\u2013Anguiano, G. et al. Comparison of specific expression profile in two in vitro hypoxia models. Exp. Ther. Med. 15, 4777\u20134784 (2018).","journal-title":"Experimental Therapeutic Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58344-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58344-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58344-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:08:05Z","timestamp":1788908885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58344-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58344"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58344-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Chongqing Medical University. The animal study protocol was approved by the Ethics Committee for the Welfare of Experimental Animals of the Chongqing Medical University (protocol code: IACUC-CQMU-20250743).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"28156"}}